| Bioactivity | SARS-CoV-2-IN-73 (compound 4) is a SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) blocker[1]. |
| Name | SARS-CoV-2-IN-73 |
| Formula | C17H18FN3O8 |
| Molar Mass | 411.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Abdulwahed Alrehaily, et al. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Sci Rep. 2023 Dec 27;13(1):23080. |